Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KLHL15 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | ARL5A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | C9orf40 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | PRDX2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | ZNF71 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | NEU1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | SUV39H2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | RP11-38C17.1 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
mRNA | SPINK2 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.003 |
mRNA | CELF1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |